5He D, Duan C, Chen J, et al. The safety and efficacy of the preoperative neoadjuvant chemotherapy for patients with cervi- cal cancer: a systematic review and meta analysis [J]. Int J Clin Exp Med ,2015,8 ( 9 ) : 14693-14700.
6Cibula D. A novel perspective of neoadjavant chemotherapy in locally advanced cervical cancer[J]. Ann Surg Oncol,2015, Nov 24. [ Epub ahead of print].
7Scandurra G, Scibilia G, Banna GL, et al. Efficacy and tolera- bility of paclitaxel, ifosfamide, and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical carcinoma [ J ]. J Gynecol Oncol,2015,26(2) :118-124.
8Shu P, Shen Y, Zhao Y, et al. A phase I study of adjuvant in- tensity-modulated radiotherapy with concurrent paclitaxel and cisplatin for cervical cancer patients with high risk factors[ J].Med Oncol,2015,32( 11 ) :247.
9Yin ZM,Yu AJ,Wu MJ,et al. Effects and toxicity of neoadju- vant chemotherapy preoperative followed by adjuvant chemo- radiation in small cell neurdendocrine cervical carcinoma[ J]. Eur J Gynaecol Onco1,2015,36 (3) :326-329.
10Tsubamoto H,Maeda H,Kanazawa R,et al. Phase I1 trial on neoadjuvant intravenous and trans-uterine arterial chemothera- py for locally advanced bulky cervical adenocarcinoma [ J ]. Gynecol Oneo1,2013,129 : 129-134.
